Delfi Diagnostics, Inc.
Biotechnology company · Palo Alto, California, United States
Delfi Diagnostics, Inc. is a biotechnology company headquartered in Palo Alto, California, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $34 million sold in a notice filed in 2025.
Delfi Diagnostics at a glance
What does Delfi Diagnostics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $34.3 million sold (2025).
Frequently asked questions about Delfi Diagnostics
Where is Delfi Diagnostics headquartered?
Delfi Diagnostics, Inc. is headquartered in Palo Alto, California, United States.
What does Delfi Diagnostics do?
Delfi Diagnostics, Inc. is a biotechnology company.
When was Delfi Diagnostics founded?
The earliest incorporation on record for Delfi Diagnostics, Inc. is in 2018, according to public company registers.
Similar companies
- Exai Bio Inc.Palo Alto, California, United States
- Kodiak Sciences Inc.Palo Alto, California, United States
- Scilex Holding CoPalo Alto, California, United States
- Immune-Onc Therapeutics, Inc.Palo Alto, California, United States
- Greenstone Biosciences, Inc.Palo Alto, California, United States
- Combinati IncPalo Alto, California, United States
- Eiger BioPharmaceuticals, Inc.Palo Alto, California, United States
- Riboscience LLCPalo Alto, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences